CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 03/31/2024 | 03/31/2023 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 42.90K | 31.50K | 46.80K | 22.30K | 22.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.90K | 31.50K | 46.80K | 22.30K | 22.30K |
| Cost of Revenue | 25.10K | 14.50K | 22.90K | 13.80K | 13.80K |
| Gross Profit | 17.70K | 17.00K | 23.90K | 8.50K | 8.50K |
| SG&A Expenses | 70.10K | 40.60K | 291.40K | 1.33M | 1.33M |
| Depreciation & Amortization | -- | -- | 13.30K | -- | -- |
| Other Operating Expenses | -- | -- | 2.80K | 3.30K | 3.30K |
| Total Operating Expenses | 95.20K | 55.10K | 330.30K | 1.35M | 1.35M |
| Operating Income | -52.40K | -23.50K | -283.50K | -1.33M | -1.33M |
| Income Before Tax | -52.40K | -23.50K | -283.50K | -1.33M | -1.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -52.40K | -23.50K | -283.50K | -1.33M | -1.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.40K | -23.50K | -283.50K | -1.33M | -1.33M |
| EBIT | -52.40K | -23.50K | -283.50K | -1.33M | -1.33M |
| EBITDA | -33.90K | -5.00K | -272.00K | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 135.69M | 135.69M | 135.69M | 115.04M | 115.04M |
| Average Diluted Shares Outstanding | 135.69M | 135.69M | 135.69M | 115.04M | 115.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
